{"id":753015,"date":"2023-05-01T08:55:54","date_gmt":"2023-05-01T12:55:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/"},"modified":"2023-05-01T08:55:54","modified_gmt":"2023-05-01T12:55:54","slug":"renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/","title":{"rendered":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride<sup>\u00ae <\/sup>Event<\/b><\/p>\n<p class=\"bwalignc\"><i>PurpleStride is Raising Awareness of the World\u2019s Toughest Cancer. Fundraising Supports Research, Critical Education, and Support Programs for Patients<\/i><\/p>\n<p>LOS ALTOS, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Frenovorx.com%2F&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=RenovoRx%2C+Inc.&amp;index=1&amp;md5=db8c51b7a7d1738a2e39d9ad650f3dd5\">RenovoRx, Inc.<\/a> (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pancan.org%2F&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=Pancreatic+Cancer+Action+Network&amp;index=2&amp;md5=707172c54056c8dd5223ccb5b011e12d\">Pancreatic Cancer Action Network<\/a> (PanCAN) as a sponsor of the organization\u2019s PurpleStride Silicon Valley event, this past Saturday, April 29, 2023. RenovoRx has sponsored PanCAN\u2019s PurpleStride Silicon Valley event for the past several years.<\/p>\n<p>\nTo help patients, improve outcomes and raise PanCAN funds, RenovoRx employees, family members, and friends created Team RenovoRx. PurpleStride Silicon Valley 2023 took place at Discovery Meadow in Downtown San Jose, California.<\/p>\n<p>\nRenovoRx CEO Shaun Bagai, commented, \u201cWe proudly support PanCAN and the PurpleStride event which is improving pancreatic cancer awareness across America. Our team is energized by meeting survivors, providers, and supporters at this important event.\u201d<\/p>\n<p>\nAccording to American Cancer Society\u2019s Cancer Facts &amp; Figures 2023, pancreatic cancer has a 5-year combined overall survival rate of 12% (Stages I-IV) and will be the second leading cause of cancer-related deaths before 2030. RenovoRx is dedicated to advancing treatment options to help extend survival and improve quality of life for patients impacted by pancreatic cancer and other difficult-to-treat cancers.<\/p>\n<p>\nSilicon Valley\u2019s PurpleStride walk is coordinated with nearly 60 other communities across the nation for one nationally synchronized PanCAN PurpleStride event. Funds raised through this nationwide movement fuel life-changing programs and services for pancreatic cancer patients and their families.<\/p>\n<p>\n\u201cBy taking action locally, we have the opportunity to make a difference in the lives of pancreatic cancer patients nationwide,\u201d said Ariane Chapple, Community Relationship Manager of PanCAN\u2019s Silicon Valley affiliate. \u201cWe are grateful to RenovoRx\u2019s commitment to raise vital funds and awareness to support the pancreatic cancer community through this important event.\u201d<\/p>\n<p>\nTo learn more about the Pancreatic Cancer Action Network and how you can make a difference, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pancan.org&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=pancan.org&amp;index=3&amp;md5=3b0b5a16514b2f1ebd54d2be29d7aa79\">pancan.org<\/a>.<\/p>\n<p><b>About the Pancreatic Cancer Action Network<\/b><\/p>\n<p>\nThe Pancreatic Cancer Action Network (PanCAN) leads the way in accelerating critical progress for pancreatic cancer patients. PanCAN takes bold action by funding life-saving research, providing personalized patient services and creating a community of supporters and volunteers who will stop at nothing to create a world in which all pancreatic cancer patients will thrive.<\/p>\n<p><b>About RenovoRx, Inc.<\/b><\/p>\n<p>\nRenovoRx is a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. Our mission is to lead a revolution in oncology therapy by delivering its innovative and targeted intra-arterial (IA) delivery of chemotherapy directly to solid tumors. The proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP<sup>\u00ae<\/sup>) therapy platform aims to avoid the harsh side effects typical of the current standard of care, or systemic delivery methods, thus improving patient well-being and, potentially extension of life, so more time may be enjoyed with loved ones. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and clinical use, with the goal of improving their safety, tolerance, and widening their therapeutic window by providing more targeted delivery at the location of the tumor tissue. RenovoRx\u2019s lead product candidate, RenovoGem\u2122, is a combination of gemcitabine and its patented delivery system, RenovoCath<sup>\u00ae<\/sup>, and is regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). RenovoGem is currently being studied in the open label, randomized Phase III TIGeR-PaC clinical trial for the treatment of LAPC.<\/p>\n<p>\nRenovoRx\u2019s patent portfolio for its therapy platform and product candidates includes eight issued U.S. patents, one issued European patent, and several additional patents pending in the US, EU and Asia. RenovoRx has been granted Orphan Drug Designation for intra-arterial delivery of gemcitabine for the treatment of both pancreatic cancer and bile duct cancer (cholangiocarcinoma).<\/p>\n<p>\nLearn more by visiting the RenovoRx <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Frenovorx.com%2F&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=website&amp;index=4&amp;md5=3b2f0ba243fd6a1b57b718170ebc8164\">website<\/a> or following RenovoRx on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Frenovorx&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=16ecfb2b7847a86f5068ddd423e0b3a2\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Frenovorx%2F%3FviewAsMember%3Dtrue&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=6f637ede4523db1519c650e9e7791217\">LinkedIn<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Frenovorx&amp;esheet=53387083&amp;newsitemid=20230428005002&amp;lan=en-US&amp;anchor=Twitter&amp;index=7&amp;md5=2b08802ae44be540d9f84643b78f0cbe\">Twitter<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230428005002\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230428005002\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>KCSA Strategic Communications<br \/>\n<br \/>Valter Pinto or Jack Perkins<br \/>\n<br \/>T:212-896-1254<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:renovorx@kcsa.com\">renovorx@kcsa.com<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Kevin Knight<br \/>\n<br \/>T: 214-732-9392<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:kknightpr@gmail.com\">kknightpr@gmail.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Oncology Philanthropy Health Fund Raising Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event PurpleStride is Raising Awareness of the World\u2019s Toughest Cancer. Fundraising Supports Research, Critical Education, and Support Programs for Patients LOS ALTOS, Calif.&#8211;(BUSINESS WIRE)&#8211;RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined Pancreatic Cancer Action Network (PanCAN) as a sponsor of the organization\u2019s PurpleStride Silicon Valley event, this past Saturday, April 29, 2023. RenovoRx has sponsored PanCAN\u2019s PurpleStride Silicon Valley event for the past several years. To help patients, improve outcomes and raise PanCAN funds, RenovoRx employees, family members, and friends created Team RenovoRx. PurpleStride Silicon Valley 2023 took place at Discovery Meadow in Downtown San Jose, California. RenovoRx CEO &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753015","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event PurpleStride is Raising Awareness of the World\u2019s Toughest Cancer. Fundraising Supports Research, Critical Education, and Support Programs for Patients LOS ALTOS, Calif.&#8211;(BUSINESS WIRE)&#8211;RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined Pancreatic Cancer Action Network (PanCAN) as a sponsor of the organization\u2019s PurpleStride Silicon Valley event, this past Saturday, April 29, 2023. RenovoRx has sponsored PanCAN\u2019s PurpleStride Silicon Valley event for the past several years. To help patients, improve outcomes and raise PanCAN funds, RenovoRx employees, family members, and friends created Team RenovoRx. PurpleStride Silicon Valley 2023 took place at Discovery Meadow in Downtown San Jose, California. RenovoRx CEO &hellip; Continue reading &quot;RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T12:55:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event\",\"datePublished\":\"2023-05-01T12:55:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/\"},\"wordCount\":710,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/\",\"name\":\"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-05-01T12:55:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/","og_locale":"en_US","og_type":"article","og_title":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk","og_description":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event PurpleStride is Raising Awareness of the World\u2019s Toughest Cancer. Fundraising Supports Research, Critical Education, and Support Programs for Patients LOS ALTOS, Calif.&#8211;(BUSINESS WIRE)&#8211;RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined Pancreatic Cancer Action Network (PanCAN) as a sponsor of the organization\u2019s PurpleStride Silicon Valley event, this past Saturday, April 29, 2023. RenovoRx has sponsored PanCAN\u2019s PurpleStride Silicon Valley event for the past several years. To help patients, improve outcomes and raise PanCAN funds, RenovoRx employees, family members, and friends created Team RenovoRx. PurpleStride Silicon Valley 2023 took place at Discovery Meadow in Downtown San Jose, California. RenovoRx CEO &hellip; Continue reading \"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T12:55:54+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event","datePublished":"2023-05-01T12:55:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/"},"wordCount":710,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/","name":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-05-01T12:55:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230428005002r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renovorx-sponsors-pancreatic-cancer-action-networks-purplestride-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RenovoRx Sponsors Pancreatic Cancer Action Network\u2019s PurpleStride\u00ae Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753015"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753015\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}